Interleukin gains GeneOb technology for obesity
This article was originally published in Clinica
Executive Summary
Interleukin Genetics, a Waltham, Massachusetts-based developer of specialised risk assessment tests, has gained exclusive licence to a genetic test panel and algorithm that identifies the specific mechanisms behind an individual's weight gain and their responses to diet and exercise.